Pre-earnings options volume in Prokidney (PROK) Corp is normal with calls leading puts 12:1. Implied volatility suggests the market is anticipating a move near 13.0%, or 35c, after results are released. Median move over the past eight quarters is 2.6%.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PROK:
- Prokidney’s REACT Study: A Promising Step for Kidney Disease Treatment
- Largest borrow rate increases among liquid names
- ProKidney’s Hold Rating: Balancing FDA Alignment and Extended Approval Timeline
- ProKidney’s Clinical Trials and Regulatory Developments Lead to Hold Rating Amid Uncertainty
- ProKidney’s Strategic FDA Alignment and Promising Clinical Data Drive Buy Rating